{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T13:06:24Z","timestamp":1795266384134,"version":"4.10.3"},"reference-count":51,"publisher":"American Chemical Society (ACS)","issue":"21","license":[{"start":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T00:00:00Z","timestamp":1602720000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-001"},{"start":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T00:00:00Z","timestamp":1602720000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-009"},{"start":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T00:00:00Z","timestamp":1602720000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The novel coronavirus disease COVID-19 that emerged in 2019 is caused by the virus SARS CoV-2 and named for its close genetic similarity to SARS CoV-1 that caused severe acute respiratory syndrome (SARS) in 2002. Both SARS coronavirus genomes encode two overlapping large polyproteins, which are cleaved at specific sites by a 3C-like cysteine protease (3CLpro) in a post-translational processing step that is critical for coronavirus replication. The 3CLpro sequences for CoV-1 and CoV-2 viruses are 100% identical in the catalytic domain that carries out protein cleavage. A research effort that focused on the discovery of reversible and irreversible ketone-based inhibitors of SARS CoV-1 3CLpro employing ligand-protease structures solved by X-ray crystallography led to the identification of 3 and 4. Preclinical experiments reveal 4 (PF-00835231) as a potent inhibitor of CoV-2 3CLpro with suitable pharmaceutical properties to warrant further development as an intravenous treatment for COVID-19.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.0c01063","type":"journal-article","created":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T11:52:13Z","timestamp":1602762733000},"page":"12725-12747","source":"Crossref","is-referenced-by-count":509,"title":["Discovery of Ketone-Based\nCovalent Inhibitors of Coronavirus\n3CL Proteases for the Potential Therapeutic Treatment of COVID-19"],"prefix":"10.1021","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2030-9094","authenticated-orcid":true,"given":"Robert L.","family":"Hoffman","sequence":"first","affiliation":[{"name":"Pfizer Worldwide Research and Development , 10770 Science Center Drive , ,","place":["San Diego, California, United States, 92121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Kania","sequence":"additional","affiliation":[{"name":"Pfizer Worldwide Research and Development , 10770 Science Center Drive , ,","place":["San Diego, California, United States, 92121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary A.","family":"Brothers","sequence":"additional","affiliation":[{"name":"Pfizer Worldwide Research and Development , 10770 Science Center Drive , ,","place":["San Diego, California, United States, 92121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay F.","family":"Davies","sequence":"additional","affiliation":[{"name":"Pfizer Worldwide Research and Development , 10770 Science Center Drive , ,","place":["San Diego, California, United States, 92121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose A.","family":"Ferre","sequence":"additional","affiliation":[{"name":"Pfizer Worldwide Research and Development , 10770 Science Center Drive , ,","place":["San Diego, California, United States, 92121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketan S.","family":"Gajiwala","sequence":"additional","affiliation":[{"name":"Pfizer Worldwide Research and Development , 10770 Science Center Drive , ,","place":["San Diego, California, United States, 92121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingying","family":"He","sequence":"additional","affiliation":[{"name":"Pfizer Worldwide Research and Development , 10770 Science Center Drive , ,","place":["San Diego, California, United States, 92121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Hogan","sequence":"additional","affiliation":[{"name":"Southern Research Institute , 2000 9th Avenue South , ,","place":["Birmingham, Alabama, United\nStates, 35205"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirk","family":"Kozminski","sequence":"additional","affiliation":[{"name":"Pfizer Worldwide Research and Development , 10770 Science Center Drive , ,","place":["San Diego, California, United States, 92121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian Y.","family":"Li","sequence":"additional","affiliation":[{"name":"Pfizer Worldwide Research and Development , 10770 Science Center Drive , ,","place":["San Diego, California, United States, 92121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6148-0579","authenticated-orcid":true,"given":"Jonathan W.","family":"Lockner","sequence":"additional","affiliation":[{"name":"Pfizer Worldwide Research and Development , 10770 Science Center Drive , ,","place":["San Diego, California, United States, 92121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihong","family":"Lou","sequence":"additional","affiliation":[{"name":"Pfizer Worldwide Research and Development , 10770 Science Center Drive , ,","place":["San Diego, California, United States, 92121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle T.","family":"Marra","sequence":"additional","affiliation":[{"name":"Pfizer Worldwide Research and Development , 10770 Science Center Drive , ,","place":["San Diego, California, United States, 92121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Lennert J.","family":"Mitchell","sequence":"additional","affiliation":[{"name":"Pfizer Worldwide Research and Development , 10770 Science Center Drive , ,","place":["San Diego, California, United States, 92121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brion W.","family":"Murray","sequence":"additional","affiliation":[{"name":"Pfizer Worldwide Research and Development , 10770 Science Center Drive , ,","place":["San Diego, California, United States, 92121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5087-0819","authenticated-orcid":true,"given":"James A.","family":"Nieman","sequence":"additional","affiliation":[{"name":"Pfizer Worldwide Research and Development , 10770 Science Center Drive , ,","place":["San Diego, California, United States, 92121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Noell","sequence":"additional","affiliation":[{"name":"Pfizer Worldwide Research and Development , 10770 Science Center Drive , ,","place":["San Diego, California, United States, 92121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8901-8992","authenticated-orcid":true,"given":"Simon P.","family":"Planken","sequence":"additional","affiliation":[{"name":"Pfizer Worldwide Research and Development , 10770 Science Center Drive , ,","place":["San Diego, California, United States, 92121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Rowe","sequence":"additional","affiliation":[{"name":"Southern Research Institute , 2000 9th Avenue South , ,","place":["Birmingham, Alabama, United\nStates, 35205"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Ryan","sequence":"additional","affiliation":[{"name":"Pfizer Worldwide Research and Development , 10770 Science Center Drive , ,","place":["San Diego, California, United States, 92121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"George J.","family":"Smith","sequence":"additional","affiliation":[{"name":"Pfizer Worldwide Research and Development , 10770 Science Center Drive , ,","place":["San Diego, California, United States, 92121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Solowiej","sequence":"additional","affiliation":[{"name":"Pfizer Worldwide Research and Development , 10770 Science Center Drive , ,","place":["San Diego, California, United States, 92121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire M.","family":"Steppan","sequence":"additional","affiliation":[{"name":"Pfizer Worldwide Research and Development , 10770 Science Center Drive , ,","place":["San Diego, California, United States, 92121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Taggart","sequence":"additional","affiliation":[{"name":"Southern Research Institute , 2000 9th Avenue South , ,","place":["Birmingham, Alabama, United\nStates, 35205"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2020,10,15]]},"reference":[{"key":"2026081717072643800_cit1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus\nassociated with human respiratory\ndisease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"2026081717072643800_cit2","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak\nassociated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"2026081717072643800_cit3","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1126\/science.1085953","article-title":"The genome sequence of the SARS-associated\ncoronavirus","volume":"300","author":"Marra","year":"2003","journal-title":"Science"},{"key":"2026081717072643800_cit4","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1126\/science.1085952","article-title":"The genome\nsequence of the SARS-associated coronavirus. Characterization of a\nnovel coronavirus associated with severe acute respiratory syndrome","volume":"300","author":"Rota","year":"2003","journal-title":"Science"},{"key":"2026081717072643800_cit5","unstructured":"World Health Organization\n          . Cumulative Number of Reported Probable\nCases, http:\/\/www.who.int\/csr\/sars\/country\/2003_06_17\/en\/index.html (accessed June 17, 2003)."},{"key":"2026081717072643800_cit6","unstructured":"John Hopkins University\n          . COVID-19\nDashboard by the Center for Systems Science and Engineering\n(CSSE) at Johns Hopkins University (JHU), https:\/\/coronavirus.jhu.edu\/map.html (accessed June 16, 2020)."},{"key":"2026081717072643800_cit7","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1099\/vir.0.19424-0","article-title":"Mechanisms and enzymes\ninvolved in SARS coronavirus genome expression","volume":"84","author":"Thiel","year":"2003","journal-title":"J. Gen. Virol."},{"key":"2026081717072643800_cit8","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure\nof SARS-CoV-2 main protease provides a basis for design of improved\n\u03b1-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"2026081717072643800_cit9","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1126\/science.abb4489","article-title":"Structure-based\ndesign of antiviral drug candidates targeting the SARS-CoV-2 main\nprotease","volume":"368","author":"Dai","year":"2020","journal-title":"Science"},{"key":"2026081717072643800_cit10","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.1021\/jm980071x","article-title":"Tripeptide\naldehyde inhibitors of human rhinovirus 3C protease: design, synthesis,\nbiological evaluation, and cocrystal structure solution of P1 glutamine\nisosteric replacements","volume":"41","author":"Webber","year":"1998","journal-title":"J. Med. Chem."},{"key":"2026081717072643800_cit11","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1016\/S0960-894X(96)00537-9","article-title":"Small peptidic aldehyde inhibitors\nof human rhinovirus 3C protease","volume":"6","author":"Shepherd","year":"1996","journal-title":"Biorg. Med.\nChem. Lett."},{"key":"2026081717072643800_cit12","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1016\/0960-894X(95)00345-T","article-title":"Glutamine-derived\naldehydes for the\ninhibition of human rhinovirus 3C protease","volume":"5","author":"Kaldor","year":"1995","journal-title":"Biorg. Med. Chem. Lett."},{"key":"2026081717072643800_cit13","doi-asserted-by":"publisher","first-page":"8172","DOI":"10.1021\/bi00025a024","article-title":"Peptide\naldehyde inhibitors of hepatitis A virus 3C proteinase","volume":"34","author":"Malcolm","year":"1995","journal-title":"Biochemistry"},{"key":"2026081717072643800_cit14","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S0968-0896(99)00011-5","article-title":"Potent dipeptidylketone\ninhibitors of the cysteine protease cathepsin K","volume":"7","author":"Marquis","year":"1999","journal-title":"Biorg. Med. Chem."},{"key":"2026081717072643800_cit15","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1016\/S0960-894X(02)00619-4","article-title":"General solid-phase\nmethod to prepare novel cyclic\nketone inhibitors of the cysteine protease cruzain","volume":"12","author":"Huang","year":"2002","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"2026081717072643800_cit16","doi-asserted-by":"publisher","first-page":"11351","DOI":"10.1021\/ja972204u","article-title":"Structure\nand design\nof potent and selective cathepsin K inhibitors","volume":"119","author":"Yamashita","year":"1997","journal-title":"J. Am. Chem. Soc."},{"key":"2026081717072643800_cit17","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1021\/ja00266a066","article-title":"Reversible\ncovalent inhibition of\npapain by a peptide nitrile. Carbon-13 NMR evidence for a thioimidate\nester adduct","volume":"108","author":"Moon","year":"1986","journal-title":"J. Am. Chem. Soc."},{"key":"2026081717072643800_cit18","unstructured":"Cowen, S. D.; Greenspan, D. P.; McQuire, L. W.; Tommasi, A. R.; Van Duzer, J. H.\n          N-substituted\npeptidyl nitriles as cysteine cathepsin inhibitors. WO01\/87828\nA1, publication date Nov 22, 2001."},{"key":"2026081717072643800_cit19","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1021\/jm00074a031","article-title":"Peptide\nalpha-keto ester, alpha-keto amide, and alpha-keto acid inhibitors\nof calpains and other cysteine proteases","volume":"36","author":"Li","year":"1993","journal-title":"J.\nMed. Chem."},{"key":"2026081717072643800_cit20","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1016\/S0960-894X(03)00753-4","article-title":"Synthesis and evaluation\nof tripeptidyl alpha-ketoamides as human rhinovirus 3C protease inhibitors","volume":"13","author":"Chen","year":"2003","journal-title":"Biorg. Med. Chem. Lett."},{"key":"2026081717072643800_cit21","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1021\/cr950025u","article-title":"Cysteine proteases and their inhibitors","volume":"97","author":"Otto","year":"1997","journal-title":"Chem. Rev."},{"key":"2026081717072643800_cit22","doi-asserted-by":"publisher","first-page":"6324","DOI":"10.1021\/ja00358a030","article-title":"Structure and stereochemistry\nof tetrahedral inhibitor complexes of papain by direct NMR observation","volume":"105","author":"Gamcsik","year":"1983","journal-title":"J. Am. Chem. Soc."},{"key":"2026081717072643800_cit23","doi-asserted-by":"publisher","first-page":"4562","DOI":"10.1021\/acs.jmedchem.9b01828","article-title":"\u03b1-Ketoamides\nas broad-spectrum inhibitors of coronavirus and enterovirus replication:\nStructure-based design, synthesis, and activity assessment","volume":"63","author":"Zhang","year":"2020","journal-title":"J. Med. Chem."},{"key":"2026081717072643800_cit24","doi-asserted-by":"publisher","first-page":"4639","DOI":"10.1021\/cr010182v","article-title":"Irreversible inhibitors\nof serine, cysteine, and threonine proteases","volume":"102","author":"Powers","year":"2002","journal-title":"Chem. Rev."},{"key":"2026081717072643800_cit25","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1021\/ja00221a062","article-title":"New inhibitors of cysteine\nproteinases. Peptidyl acyloxymethyl ketones and the quiescent nucleofuge\nstrategy","volume":"110","author":"Smith","year":"1988","journal-title":"J. Am. Chem. Soc."},{"key":"2026081717072643800_cit26","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1021\/jm00031a003","article-title":"P1 aspartate-based peptide alpha-((2,6-dichlorobenzoyl)\u00adoxy)\u00admethyl\nketones as potent time-dependent inhibitors of interleukin-1 beta-converting\nenzyme","volume":"37","author":"Dolle","year":"1994","journal-title":"J. Med. Chem."},{"key":"2026081717072643800_cit27","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/S0968-0896(99)00009-7","article-title":"A catalytic mechanism for caspase-1\nand for bimodal inhibition of caspase-1 by activated aspartic ketones","volume":"7","author":"Brady","year":"1999","journal-title":"Bioorg. Med. Chem."},{"key":"2026081717072643800_cit28","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1126\/science.1085658","article-title":"Coronavirus\nmain proteinase (3CLpro) structure: basis for design of\nanti-SARS drugs","volume":"300","author":"Anand","year":"2003","journal-title":"Science"},{"key":"2026081717072643800_cit29","unstructured":"The X-ray crystallographic coordinates for the SARS CoV-1 3CLpro covalently bound with inhibitor 2 is deposited\nin the Protein Data Bank (PDB), http:\/\/rcsb.rutgers.edu\/pdb\/index (PDB code 6XHO)."},{"key":"2026081717072643800_cit30","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1021\/jm9805384","article-title":"Structure-based\ndesign, synthesis, and biological evaluation of irreversible human\nrhinovirus 3C protease inhibitors. 4. Incorporation of P1 lactam moieties\nas L-glutamine replacements","volume":"42","author":"Dragovich","year":"1999","journal-title":"J. Med. Chem."},{"key":"2026081717072643800_cit31","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1021\/jm00099a008","article-title":"New hydroxyethylamine\nHIV protease inhibitors that suppress viral replication","volume":"35","author":"Rich","year":"1992","journal-title":"J. Med. Chem."},{"key":"2026081717072643800_cit32","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1021\/cc9800374","article-title":"Solid-phase synthesis\nof a combinatorial array of 1,3-bis\u00ad(acylamino)-2-butanones, inhibitors\nof the cysteine proteases cathepsins K and L","volume":"1","author":"Yamashita","year":"1999","journal-title":"J. Comb. Chem."},{"key":"2026081717072643800_cit33","doi-asserted-by":"publisher","first-page":"6807","DOI":"10.1016\/S0040-4039(01)01416-2","article-title":"An efficient\nsynthesis of a key intermediate for the\npreparation of the rhinovirus protease inhibitor AG7088 via asymmetric\ndianionic cyanomethylation of N-Boc-L-(+)-glutamic acid dimethyl ester","volume":"42","author":"Tian","year":"2001","journal-title":"Tetrahedron Lett."},{"key":"2026081717072643800_cit35","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1016\/S0960-894X(02)00611-X","article-title":"Novel route to the synthesis of peptides\ncontaining 2-amino-1\u2032-hydroxymethyl ketones and their application\nas cathepsin K inhibitors","volume":"12","author":"Mendonca","year":"2002","journal-title":"Biorg. Med. Chem.\nLett."},{"key":"2026081717072643800_cit37","doi-asserted-by":"publisher","first-page":"4678","DOI":"10.1021\/bi00233a007","article-title":"Peptidyl\n(acyloxy)\u00admethyl ketones and the quiescent affinity label concept:\nthe departing group as a variable structural element in the design\nof inactivators of cysteine proteinases","volume":"30","author":"Krantz","year":"1991","journal-title":"Biochemistry"},{"key":"2026081717072643800_cit38","unstructured":"The X-ray crystallographic coordinates for the SARS\nCoV-1 and SARS\nCoV-2 3CLpro each covalently bound inhibitor 28 are deposited\nin the Protein Data Bank (PDB), http:\/\/rcsb.rutgers.edu\/pdb\/index (PDB Code 6XHN)."},{"key":"2026081717072643800_cit39","unstructured":"Hoffman, R. L.; Kania, R. S.; Nieman, J. A.; Planken, S. P.; Smith, G. J., III.\n          SARS antiviral data for all described inhibitors are disclosed. Preparation of peptides as anticoronaviral agents. WO2005\/113580\nA1, Dec 1, 2005."},{"key":"2026081717072643800_cit43","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0968-0896(02)00427-3","article-title":"Crystal structures\nof reversible\nketone-Based inhibitors of the cysteine protease cruzain","volume":"11","author":"Huang","year":"2003","journal-title":"Biorg. Med. Chem."},{"key":"2026081717072643800_cit44","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1042\/BJ20041142","article-title":"The protein structures\nthat shape caspase activity,\nspecificity, activation and inhibition","volume":"384","author":"Fuentes-Prior","year":"2004","journal-title":"Biochem.\nJ."},{"key":"2026081717072643800_cit45","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/S0090-9556(24)14938-0","article-title":"Prediction\nof human clearance of twenty-nine drugs from hepatic microsomal intrinsic\nclearance data: an examination of in vitro half-life approach and\nnonspecific binding to microsomes","volume":"27","author":"Obach","year":"1999","journal-title":"Drug Metab.\nDispos."},{"key":"2026081717072643800_cit47","unstructured":"The X-ray crystallographic\ncoordinates for the SARS CoV-1 3CLpro (PDB Code 6XHL) and\nSARS CoV-2 3CLpro (6XHM)\neach covalently bound inhibitor 4 are deposited in the\nProtein Data Bank (PDB), http:\/\/rcsb.rutgers.edu\/pdb\/index."},{"key":"2026081717072643800_cit48","first-page":"3944","article-title":"P-glycoprotein\nand cytochrome P-450\n3A inhibition: dissociation of inhibitory potencies","volume":"59","author":"Wandel","year":"1999","journal-title":"Cancer Res."},{"key":"2026081717072643800_cit50","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.virusres.2007.02.015","article-title":"Evaluating\nthe 3C-like protease activity of SARS-Coronavirus: recommendations\nfor standardized assays for drug discovery","volume":"133","author":"Grum-Tokars","year":"2008","journal-title":"Virus Res."},{"key":"2026081717072643800_cit51","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/0378-4274(85)90046-3","article-title":"Toxicity determined\nin vitro by morphological alterations\nand neutral red absorption","volume":"24","author":"Borenfreund","year":"1985","journal-title":"Toxicol. Lett."},{"key":"2026081717072643800_cit52","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jviromet.2017.03.012","article-title":"Evaluation of cell\nviability dyes in antiviral assays with RNA viruses that exhibit different\ncytopathogenic properties","volume":"246","author":"Smee","year":"2017","journal-title":"J. Virol. Methods"},{"key":"2026081717072643800_cit53","first-page":"4827","article-title":"Evaluation\nof a soluble tetrazolium\/formazan assay for cell growth and drug sensitivity\nin culture using human and other tumor cell lines","volume":"48","author":"Scudiero","year":"1988","journal-title":"Cancer Res."},{"key":"2026081717072643800_cit54","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1093\/jnci\/81.8.577","article-title":"New soluble-formazan assay for HIV-1 cytopathic effects:\napplication to high-flux screening of synthetic and natural products\nfor AIDS-antiviral activity","volume":"81","author":"Weislow","year":"1989","journal-title":"J. Natl. Cancer\nInst."},{"key":"2026081717072643800_cit55","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0166-3542(95)00976-0","article-title":"A rapid assay for\ndetermination of antiviral activity\nagainst human cytomegalovirus","volume":"32","author":"Hippenmeyer","year":"1996","journal-title":"Antiviral Res."},{"key":"2026081717072643800_cit56","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1128\/AAC.43.10.2444","article-title":"In vitro\nantiviral\nactivity of AG7088, a potent inhibitor of human rhinovirus 3C protease","volume":"43","author":"Patick","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"2026081717072643800_cit57","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1126\/science.290.5498.1972","article-title":"Efficient initiation of HCV RNA replication\nin cell culture","volume":"290","author":"Blight","year":"2000","journal-title":"Science"},{"key":"2026081717072643800_cit58","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1021\/bi702107v","article-title":"Steady-state and pre-steady-state\nkinetic evaluation\nof severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro cysteine protease: development of an ion-pair model for\ncatalysis","volume":"47","author":"Solowiej","year":"2008","journal-title":"Biochemistry"}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.0c01063","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/63\/21\/12725\/13401762\/jm0c01063.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/63\/21\/12725\/13401762\/jm0c01063.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:18:43Z","timestamp":1787001523000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/63\/21\/12725\/501385\/Discovery-of-Ketone-Based-Covalent-Inhibitors-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,15]]},"references-count":51,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2020,10,15]]},"published-print":{"date-parts":[[2020,11,12]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.0c01063","relation":{"has-preprint":[{"id-type":"doi","id":"10.26434\/chemrxiv.12631496","asserted-by":"object"},{"id-type":"doi","id":"10.26434\/chemrxiv.12631496.v1","asserted-by":"object"}],"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.jmedchem.0c01063.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.jmedchem.0c01063.s002","asserted-by":"subject"}]},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,15]]}}}